1 Maryland SPAP Premium Subsidies to MedicareRx Plans National Association of Comprehensive Health Insurance Plans October 16, 2008 Richard Popper Executive.

Slides:



Advertisements
Similar presentations
Optima Medicare (PPO) Plans CY Medicare Medicare is a Federal health insurance program for those age 65 or older or individuals at any age who have.
Advertisements

Part Ds Low-Income Benefits: Theory and Reality Marc Steinberg, Families USA Health Action 2006 January 26, 2006 ** Washington, DC
1 Filling the Holes in Part D: SPAPs to the Rescue? Marc Steinberg, Families USA Health Action 2005 * January 27,
Medicare Part D John A. Geib 10/3/05. Medicare Modernization Act (MMA) 2003 and How the MMA impacts California’s Medi-Cal Program Largest change in healthcare.
ROBIN LUNGE DIRECTOR OF HEALTH CARE REFORM NOVEMBER 18, 2011 Integration of Medicaid and the Exchange.
Adam J. Falk, Esq. FELDESMAN TUCKER LEIFER FIDELL LLP Legal issues for Medicaid Plans Under Part D in Serving Dual Eligibles MEDICAID HEALTH PLANS OF AMERICA.
Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy.
Healthy Indiana Plan Hoosier Innovation: Health Savings Accounts 1992: Hoosier pioneers medical savings accounts 2003: Tax advantaged HSAs authorized.
 Medicare Drug Rebates  Medicare patients who face a gap in prescription drug coverage would received a one-year, $250 rebate to help pay for medication.
Y0096_MRK_OK_PDSALPRE15 APPROVED bcbsok.com Your presenter today: Bob Archer Health Insurance Enrollment Center.
2006 Retiree MIP Overview October 2006 Rajiv Nundy & Kent Humphries HR Compensation Management.
The Evolving Role of States in the Medicare Drug Benefit Thomas M. Snedden, Director Pennsylvania PACE Program The Third National Medicare Congress October.
North Carolina AIDS Drug Assistance Program (ADAP) State Pharmaceutical Assistance Program (SPAP)
THE AIDS INSTITUTE The AIDS Institute HEALTH REFORM AND ADAP Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director AIDS Drug.
MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.
1 Exchange, Basic Health Program & Medicaid: Connecting the Coverage Dots for Low-Income Health Care Consumers Medicaid Managed Care Conference October.
Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.
Medicare Prescription Drug Coverage Extra Help with Medicare Prescription Drug Costs for Those Who Need it Most.
Medicare Prescription Drug Coverage. What’s Different About Prescription Drug Information? One size does not fit all, more than ever before Distinct messages.
Medicare Modernization Act, Part D Prescription Drug Benefit Presentation for County Program Administrators September 1, 2005.
Joint Informational Hearing The Federal Medicare Prescription Drug Act: State Readiness, Implementation, and Consumer Issues Bonnie Burns, Training and.
The New Health Care Reform: Explaining Changes To Medicare Beneficiaries.
MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.
Presented by Jennifer Kluge Michigan Business and Professional Association.
1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
Medicare in Minnesota 2012 Your Medicare: Making the Best Possible Decisions October 2011 Presented by Stephanie Minor Senior LinkAge Line® Program Consultant.
Patient Advocacy. Access, Affordability, and understanding treatment costs.
Medicare Prescription Drug Benefit: Part D Health & Disability Advocates Stephanie Altman, J.D Ext
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Roy Trudel, CMSO National Eligibility Workers Association 07/12/05.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
What Difference Will It Make for People with Disabilities? Michael Dalto Maryland Department of Disabilities December 8,
January National Medicare & You Training Program Amy Larrick, CMS NAACP April 27, 2006.
The Rolling Hills Group Creating the Plan for Healthcare Reform for Tennessee.
Introduction to Medicare and Medi-Cal for Seniors.
Medicare and Patient Assistance Sean M. Dougherty Senior Director Medicare Strategy & Patient Assistance Programs Government, Public Policy And Managed.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
The Patient Protection & Affordable Coverage Act of 2010 as Amended (by the Health Care and Education Affordability Reconciliation Act) How Its Provisions.
Pennsylvania’s CHIP Expansion to Cover All Uninsured Kids.
Medicare Part D Symposium Thursday, September 1, 2005 Sacramento, CA Cathy Senderling Senior Legislative Advocate, CWDA.
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
THE COMMONWEALTH FUND Medicare Part D: What Are The Concerns? Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund Association.
1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.
11/8/051 Medicare Prescription Drug Benefits Employee Workshop November 2005.
0 Beneficiary Choices in Medicare Part D and Plan Features in 2006 Supported by PhRMA September 13, 2006.
Avalere Health LLC | The intersection of business strategy and public policy The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries.
1. 2 Governor Doyle’s Health Care Vision  Every Wisconsin resident has a right to health care.  State government must do what it can to ensure that.
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
0 Florida’s Medicaid Reform National Medicaid Congress June 5, 2006 Thomas W. Arnold Deputy Secretary for Medicaid.
Comprehensive Health Care Reform in Vermont: The Policy and Politics Jim Maxwell, PhD Herb Olson, JD JSI Research & Training Institute, Inc. Vermont Department.
Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.
1 Cost Sharing for Low-Income Beneficiaries and Supplementing Part D Examples from Pharmacy Plus Medicaid Demonstration Programs Summit for State Health.
Karissa A. Laur Director, Prescription Assistance Programs Coordinating Patient Assistance Programs with Medicare Part D: A Manufacturer’s Perspective.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Deirdre Duzor Director, Pharmacy Division Centers for Medicare & Medicaid Services.
Medicare Prescription Drug Congress MMA and Medicaid Gale Arden Director, Disabled & Elderly Health Programs Group CMSO CMS October 2005.
National Conference of State Legislatures National Medicaid Congress June 5, 2006 State Pharmaceutical Assistance Programs, Medicaid & Part D: 2006 State.
Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.
State Responses to Medicare Part D Presented by: Kimberley Fox, Senior Policy Analyst, Institute for Health Policy Academy Health Annual Research Meeting.
Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.
1 Medicare Prescription Drug Coverage AKA Medicare Part D Or Medicare Modernization Act MMA.
2018 Medicare Prescription Drug Benefit
Director, Pennsylvania PACE Program National Medicare Congress
Cost Sharing Under Part D: Impact on Beneficiaries with the Standard Benefit Bruce Stuart, PhD Director, Peter Lamy Center on Drug Therapy and Aging.
Healthcare Reform and Medicare Part D
State Implementation of MMA
2019 Medicare Prescription Drug Benefit
Medicare Rx Drug Benefit
Presented by Tricia Neuman, Sc.D.
Medicare Reform: Implications for Pharmaceutical Manufacturers
Presentation transcript:

1 Maryland SPAP Premium Subsidies to MedicareRx Plans National Association of Comprehensive Health Insurance Plans October 16, 2008 Richard Popper Executive Director Maryland Health Insurance Plan

2 What is an SPAP? State Pharmaceutical Assistance Program Established in certain states, starting in 1970’s to provide drug coverage to limited income Medicare recipients or other non- Medicare uninsured lacking Rx coverage Serve populations similar to risk pools – self employed/small business retirees, widows and divorcees who lack employer-sponsored retiree Rx coverage Serve individuals with income/resources that exceed standards for dual Medicaid/Medicare eligibility (which provides low or no-cost comprehensive Rx coverage) Largely state general fund subsidized, and often managed by state Medicaid unit Some state enrollment large – PA, NY, NJ each have appx. 100,000 members

3 SPAPs & Implementation of Medicare Part D 24 state SPAPs were induced to enroll members into MedicareRx in 2006, to shift state costs to federal government SPAPs and Medicaid instrumental in MedicareRx early enrollment success due to auto-assigment SPAPs did not close after Part D due to disparities between State programs and Medicare: –Formulary limits (no Benzodiazephine & barbiturates) and varieties among plans –MedicareRx copays higher than expiring SPAP, especially for brand drugs ($20 vrs $94 copay) –MedicareRx monthly premiums often higher ($10 vrs. $104) –Part D coverage gap (“donut hole”) of up to $3,454 in 2009 once annual drug costs exceed $2,700 –Numerous, numerous Part D plan (PDP) options in states (97 in Maryland), vs. expiring single monopoly state plan –Federal low income subsidy (LIS-”Extra Help”) has low eligibility threshold:150% of poverty ($15,600 income) & $11,900 cash resources

4 Medicare Part D: Costs and Choices Rise with Income Above 150% of poverty Standard Medicare Drug Program (average costs) Below 150% of poverty + $11,990 in assets Costs with Full Federal Extra Help – Low Income Subsidy Costs with Maryland SPDAP Assistance Monthly Premium$33$0Average $8 per month ($33-25 = $8). Optional DeductibleUp to $275$0Up to $265 Co-Insurance for Drug Usage up to $2,510 Average of 25% of the drug costs up to $2,510 $025% of the drug costs up to $2,400 Direct out of pocket Costs for costs Between $2,510 - $5,726 Up to $3,216$1-$3Up to $2,116 ($1,200 subsidy) Direct Costs for Drug Usage Over $5,726 5% of the costs above $5,726 Plan Options9725

5 SPAPs Reconfigured Under MedicareRx SPAPs now provide: wrap-around subsidies/benefits to Part D Education & enrollment assistance in choosing option State copay/coinsurance subsidies is only funding (other than independent charities or family contrib.) that counts toward coverage gap “True out of pocket costs” (TrOOP) to help member reach “other shore” of coverage gap, into Part D catastrophic coverage –Employer subsidies don’t –Ryan White funding doesn’t –Pharmaceutical industry charities don’t

6 Federal Requirements of SPAPs Can’t be directly funded by MedicareRx plans Can’t discriminate in coordinating with preferred or subset of MedicareRx plan options in state Must coordinate state subsidies with all MedicareRx plans which SPAP members choose to enroll Some exceptions where state is individual’s authorized representative, or state issues an RFP solicitation to PDPs with “reasonable” and “legitimate” purpose for coordinating care of members with a subset of PDPs

7 SPAP Administrative Options CMS guidelines for SPAPs in Part D “Coordination of Benefits” guidance 1) Hire a PBM for point of sale 3 rd party payor of copays, coinsurance or non- covered drugs Advantage - SPAP has some control over subsidy - PBM can coordinate with all PDPs - Can subsidize all phases of MedicareRx ConLots of payment reconciliation and reimbursement with PDPs 2) Enter into lump sum funding arrangements directly with MedicareRx plans willing to negotiate AdvantagePDP responsible for administration of state subsidy ConNot all PDPs required to administer wrap around subsidies 3) Subsidize MedicareRx premiums Con Must coordinate with ALL MedicareRx plans Does not assist members with significant drug costs

8 Maryland Senior Prescription Drug Assistance Program (SPDAP) Currently Assists 26,000 Marylanders with income below 300% fpl, who are ineligible for 100% LIS, by reducing their Medicare Rx premium by up to $25 per month, under any Medicare Prescription Drug Plan or Medicare Advantage New $1,200 Coverage Gap (donut hole) subsidy in

9 Maryland SPDAP “Landscape” In Drug Plan sponsors, offering 47 options In 2007 – 24 Drug Plan sponsors, offering 54 options In Drug Plan sponsors, offering 97 options Approximately 388 different MedicareRx plan payment variations, including standard premiums, and 25%, 50%, 75% LIS variation Only 13% of Maryland SPAP participants are eligibe for partial federal subsidies ( % fpl)

10

11

12

13 Approximately Half of those in Coverage Gap have costs under $1,200

MEDICARE PART D YEARLY COSTS FOR AN ACTUAL SPDAP MEMBER – Plan A (Less expensive than plan B $1,846) ATENOLOL TAB 50MG HYDROCHLOROTHIAZIDE TAB 25MG LORAZEPAM TAB 0.5MG Lotrel CAP 10-20mg Lotrel CAP 5-20mg LOVASTATIN TAB 40MG SPIRONOLACTONE TAB 50MG

15 Impact of $1,200 Coverage Gap Subsidy

16 Contract Administrators Key Maryland directly contracted with Affiliated Computer Services, Inc (ACS) to implement and run SPDAP, Oct 05 to Dec 07. Over 50,000 calls and 600,000 subsidy payments made Competitive solicitation awarded contract to Pool Administrators, Inc (PAI), effective Jan 08. PAI developed proprietary SQL payment application and is assisting in coverage gap subsidy implementation. Key to successful subsidy coordination of payments for 25,000 members among 97 MedicareRx options is CMS COB interface, where monthy file exchange thru CMS tells SPAP what PDP option each member is in, and also informs Rx plans of SPAP eligibility

17 SPDAP Outreach Efforts SPDAP has held 200 community enrollment & education events throughout Maryland since Sept. 2005, attended by 8,000 individuals (35% of program participants). Conducted by SPDAP outreach contractor gkv Reach, and MHIP staff. Approximately 68,000 calls have been answered or made by program between September 05 thru August coverage gap events throughout Maryland are planned for October-December 2008